ENTRY       D12179                      Drug
NAME        Tesnatilimab (USAN/INN)
FORMULA     C6386H9862N1688O2015S40
EXACT_MASS  143716.9952
MOL_WEIGHT  143805.3351
SEQUENCE    (Heavy chain)
            QVHLQESGPG LVKPSETLSL TCTVSDDSIS SYYWSWIRQP PGKGLEWIGH ISYSGSANYN
            PSLKSRVTIS VDTSKNQFSL KLSSVTAADT AVYYCANWDD AFNIWGQGTM VTVSSASTKG
            PSVFPLAPCS RSTSESTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL
            SSVVTVPSSS LGTKTYTCNV DHKPSNTKVD KRVESKYGPP CPPCPAPEFL GGPSVFLFPP
            KPKDTLMISR TPEVTCVVVD VSQEDPEVQF NWYVDGVEVH NAKTKPREEQ FNSTYRVVSV
            LTVLHQDWLN GKEYKCKVSN KGLPSSIEKT ISKAKGQPRE PQVYTLPPSQ EEMTKNQVSL
            TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSRLTVDKS RWQEGNVFSC
            SVMHEALHNH YTQKSLSLSL GK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS SSYLAWYQQK PGQAPRLLIY GASSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYGSSPWTFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H95, H129-L215, H142-H198, H221-H'221, H224-H'224, H256-H316, H362-H420, H'22-H'95, H'129-L'215, H'142-H'198, H'256-H'316, H'362- H'420, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
EFFICACY    Anti-inflammatory disease
  TYPE      Monoclonal antibody
COMMENT     Treatment of Crohn's disease
TARGET      KLRK1 (CD314, NKG2D) [HSA:22914] [KO:K06728]
  PATHWAY   hsa04650(22914)  Natural killer cell mediated cytotoxicity
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                KLRK1 (CD314, NKG2D)
                 D12179  Tesnatilimab (USAN/INN)
DBLINKS     CAS: 2242758-08-1
///
